Comfort Systems USA Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Comfort Systems USA Inc trades at $1,720 (market cap $61.29B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Comfort Systems USA Inc is far larger — about 2.4× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Comfort Systems USA Inc for 41 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| FIX | RPRX | |
|---|---|---|
Market Cap | $61.29B | $25.27B |
Volume | 365,637 | 3,671,183 |
Sector | Industrials | Health |
52-Week High | $2.07K | $63.96 |
52-Week Low | $790.72 | $35.44 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | $59.76B | $32.50B |
Dividend Yield | 0.21% | 1.66% |
Signals from Pluang's Aura AI — not financial advice
Comfort Systems USA (FIX) trades at $1,741.36, down 4.21% today but maintains strong technical momentum with bullish moving averages. The company demonstrates robust fundamentals with revenue growth from $9.1B in 2025 to $11.2B projected for 2026, supported by consistent earnings beats and a 55.29% ROE. Recent acquisition of Hunt Electric adds $250M in annual revenue, positioning FIX to capitalize on data center and infrastructure demand.
Outlook remains positive with analyst consensus at Buy (55.56%) and $2,080 price target representing 19% upside. Key risks include execution of growing project backlog and sensitivity to construction cycle fluctuations. The stock's premium valuation (P/E 42.86) requires sustained high growth to justify current levels amid competitive market conditions.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →